Feasibility Research On The Hypoglycemics B Project Of A Pharmacy Company

Diabetes is currently a threat to the most important non communicable diseases of global human health.Diabetes mellitus and its complications in China lead to 1 million deaths each year,and the age of death is gradually younger.Hypoglycemics B of Japanese Takeda original research,is the first orally once a week long effective hypoglycemic drugs,can be used as a single agent,but also with other oral hypoglycemic drug combination,which has a unique mechanism of action,play a long acting hypoglycemic effect by oral administration,does not produce low sugar,does not cause weight gain,low incidence of gastrointestinal adverse reactions,side effects and other unique advantages,market prospects.Under this background,hypoglycemics B project is proposed by A Pharmacy Company.This paper studies the feasibility of around A pharmaceutical company of hypoglycemic drugs in the B project,a detailed analysis of the research background,research status at home and abroad,hypoglycemic drugs B general description of project,the macroscopic environment,the market situation,technical feasibility,project risk and response measures,as diabetes drug B project selection is scientific and feasible the.(1)A pharmaceutical company hypoglycemic drugs B project overview,market conditions are analyzed in detail,similar products in the domestic and foreign market,the market demand forecasting,analysis,competitor analysis,price trend analysis of social benefits are analyzed in detail,hypoglycemic drugs B has long acting hypoglycemic mechanism,a week to take a good patient compliance,ideal glycemic control effect,the side effect is small,and the cost is low,profit space is large,the drug more advantages and competitiveness than the existing mainstream short acting DPP-4 inhibition,market prospects;(2)Technical environment of A pharmaceutical company hypoglycemic drugs B project are analyzed,the required antidiabetic B project personnel,equipment,technology and environment has obvious advantages,has launched the project technology and environmental conditions;(3)Technical scheme of A Pharma hypoglycemic drugs B project and implementation scheme are analyzed in detail,the raw material synthesis route,formulation composition,preparation process have been successfully explored that technology is feasible;(4)The risk of hypoglycemic drugs in A pharmaceutical company B project are analyzed and evaluated,aiming at medium and high risk may exist in the project development process,put forward the corresponding solutions and strategies to ensure the smooth progress of the project.Through the above comprehensive analysis and objective evaluation,it is considered that the selection of hypoglycemic drug B project of A pharmaceutical company is scientific and feasible,which provides theoretical support for the implementation of hypoglycemic drug B project.